102460.KO Reyon Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Korea Stock Exchange
9,310 KRW
Close of Nov 5, 2026
9,000 13,200
Market cap
KRW 171B
P/E
-
P/B
0.88x
ROE
-18.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 102460.KO undervalued?

Graham number

The Graham number of Reyon Pharmaceutical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Reyon Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Reyon Pharmaceutical Co Ltd yet.

Reyon Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Reyon Pharmaceutical Co Ltd

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hem…

Full company profile